KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Current Assets (2016 - 2022)

Palvella Therapeutics (PVLA) has disclosed Current Assets for 11 consecutive years, with $7.5 million as the latest value for Q4 2023.

  • On a quarterly basis, Current Assets fell 89.72% to $7.5 million in Q4 2023 year-over-year; TTM through Dec 2023 was $7.5 million, a 89.72% decrease, with the full-year FY2023 number at $7.5 million, down 89.72% from a year prior.
  • Current Assets was $7.5 million for Q4 2023 at Palvella Therapeutics, down from $59.1 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $137.6 million in Q3 2021 to a low of $7.5 million in Q4 2023.
  • A 5-year average of $89.9 million and a median of $90.9 million in 2022 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: surged 68.55% in 2021, then tumbled 89.72% in 2023.
  • Palvella Therapeutics' Current Assets stood at $115.0 million in 2019, then crashed by 34.16% to $75.7 million in 2020, then soared by 68.55% to $127.6 million in 2021, then tumbled by 42.47% to $73.4 million in 2022, then crashed by 89.72% to $7.5 million in 2023.
  • Per Business Quant, the three most recent readings for PVLA's Current Assets are $7.5 million (Q4 2023), $59.1 million (Q3 2023), and $66.5 million (Q2 2023).